Information Provided By:
Fly News Breaks for February 7, 2020
CBT
Feb 7, 2020 | 06:04 EDT
UBS analyst Joshua Spector upgraded Cabot to Buy from Neutral with a price target of $52, up from $50. The recent share weakness reflects temporary China risk from coronavirus, says the analyst, who sees upside as the company moves past what will likely be a negative comp in the March quarter. Past this, favorable contract settlements in Reinforcement Materials and stabilizing autos will benefit Cabot's CBT's margins, leading to an inflection in earnings growth, Spector tells investors in a research note.
News For CBT From the Last 2 Days
CBT
Mar 26, 2024 | 16:48 EDT
Mizuho initiated coverage of Cabot with a Buy rating and $104 price target as part of a broader research note on Carbon Black. The firm has a preference for Cabot, stating it has a more diversified portfolio including higher growth inkjets, batteries verticals, and fumed silica, the analyst tells investors in a research note. Cabot's forward earnings estimates should keep rising, in part because it appears to still be benefiting from the ban on Russian products, the firm added.